Plasma Lipidomics Approach in Early and Specific Alzheimer’s Disease Diagnosis

Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer’s Disease from Controls and Predict Progression from Mild Cognitive Impairment

(2021) Daniel A. Llano et al.   JOURNAL OF ALZHEIMERS DISEASE

Implications of Glycosylation in Alzheimer’s Disease

(2021) Henriette Haukedal et al.   Frontiers in Neuroscience

Characterization of brain‐derived extracellular vesicle lipids in Alzheimer's disease

(2021) Huaqi Su et al.   Journal of Extracellular Vesicles

Plasma Sphingomyelins in Late-Onset Alzheimer’s Disease

(2021) Gianna Fote et al.   JOURNAL OF ALZHEIMERS DISEASE

Plasma lipidome is dysregulated in Alzheimer’s disease and is associated with disease risk genes

(2021) Yue Liu et al.   Translational Psychiatry

Serum Metabolites Differentiate Amnestic Mild Cognitive Impairment From Healthy Controls and Predict Early Alzheimer's Disease via Untargeted Lipidomics Analysis

(2021) Lumi Zhang et al.   Frontiers in Neurology

Sphingomyelins and ceramides: possible biomarkers for dementia?

(2021) Laura M.I. Loft et al.   CURRENT OPINION IN LIPIDOLOGY

Lipid Profiling of Alzheimer’s Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism

(2021) Sumeyya Akyol et al.   Cells

Lipids and Alzheimer’s Disease

(2020) Yu-Chia Kao et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Early diagnosis and treatment of Alzheimer’s disease: new definitions and challenges

(2020) Marcos Pais et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Perspective: The Potential Role of Circulating Lysophosphatidylcholine in Neuroprotection against Alzheimer Disease

(2020) Richard D Semba   Advances in Nutrition

Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies

(2020) Hannah Chew et al.   Frontiers in Physiology

Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer’s Disease

(2020) Moira Marizzoni et al.   JOURNAL OF ALZHEIMERS DISEASE

Untargeted lipidomics reveals progression of early Alzheimer’s disease in APP/PS1 transgenic mice

(2020) Xueju Zhang et al.   Scientific Reports

Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid beta and cholesterol homeostasis in blood-brain barrier endothelial cells

(2019) Elham Fanaee-Danesh et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker

(2019) Carmen Peña-Bautista et al.   Journal of Proteomics

New tools and resources in metabolomics: 2016-2017

(2018) Biswapriya B. Misra   ELECTROPHORESIS

Multifactorial Hypothesis and Multi-Targets for Alzheimer’s Disease

(2018) Cheng-Xin Gong et al.   JOURNAL OF ALZHEIMERS DISEASE

Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer’s Disease Mimic Accelerated Aging

(2018) Fabian Dorninger et al.   JOURNAL OF ALZHEIMERS DISEASE

Augmented frontal cortex diacylglycerol levels in Parkinson’s disease and Lewy Body Disease

(2018) Paul L. Wood et al.   PLoS One

Plasma Sphingomyelins are Associated with Cognitive Progression in Alzheimer's Disease

(2018) Michelle M. Mielke et al.   JOURNAL OF ALZHEIMERS DISEASE

Plasma and Brain Fatty Acid Profiles in Mild Cognitive Impairment and Alzheimer's Disease

(2018) Stephen C. Cunnane et al.   JOURNAL OF ALZHEIMERS DISEASE

LipidMS: An R Package for Lipid Annotation in Untargeted Liquid Chromatography-Data Independent Acquisition-Mass Spectrometry Lipidomics

(2018) María Isabel Alcoriza-Balaguer et al.   ANALYTICAL CHEMISTRY

Phospholipid oxidation and carotenoid supplementation in Alzheimer’s disease patients

(2017) O.S. Ademowo et al.   FREE RADICAL BIOLOGY AND MEDICINE

The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer’s Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging

(2017) Michelle M. Mielke et al.   JOURNAL OF ALZHEIMERS DISEASE

Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer’s Disease

(2016) Yi Xing et al.   JOURNAL OF ALZHEIMERS DISEASE

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

(2016) Clifford R. Jack et al.   NEUROLOGY

Ceramides in Alzheimer’s Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and AβAccumulation

(2015) Maja Jazvinšćak Jembrek et al.   Oxidative Medicine and Cellular Longevity

Identifying Small Molecules via High Resolution Mass Spectrometry: Communicating Confidence

(2014) Emma L. Schymanski et al.   ENVIRONMENTAL SCIENCE & TECHNOLOGY

The Involvement of Lipids in Alzheimer's Disease

(2014) Wei Ling Florence Lim et al.   Journal of Genetics and Genomics

Lysophosphatidylcholine and Amide as Metabolites for Detecting Alzheimer Disease Using Ultrahigh-Performance Liquid Chromatography–Quadrupole Time-of-Flight Mass Spectrometry–Based Metabonomics

(2014) Yu Cui et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Ceramides and sphingomyelinases in senile plaques

(2014) Maï Panchal et al.   NEUROBIOLOGY OF DISEASE

Amyloid-β and Tau

(2014) George S. Bloom   JAMA Neurology

Alterations in cerebrospinal fluid glycerophospholipids and phospholipase A2activity in Alzheimer's disease

(2013) Alfred N. Fonteh et al.   JOURNAL OF LIPID RESEARCH